Whilst I am also doubtful, as I have said before I can envision Clever Cultures as an "industry standard" .If we think of India as the third largest pharmaceutical manufacturer. It is likely to be hit with Trump Tariffs. If that is not enough to move manufacturing back to the US why not challenge their quality control processes and make life difficult..This could require manufacturers meet a testing "industry standard" which the FDA may require for pharmaceuticals to enter the USA.Who knows how things will play out. The biggest risk is that Clever Cultures will be taken over before the potential can be realized.
(20min delay)